Transcend Capital Advisors’s BlackRock Science and Technology Term Trust BSTZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-15,559
Closed -$257K 511
2023
Q3
$257K Buy
15,559
+182
+1% +$3.22K 0.03% 399
2023
Q2
$278K Buy
15,377
+186
+1% +$3.2K 0.03% 384
2023
Q1
$284K Sell
15,191
-283
-2% -$4.97K 0.03% 372
2022
Q4
$242K Sell
15,474
-19,619
-56% -$334K 0.03% 410
2022
Q3
$619K Buy
35,093
+540
+2% +$11.1K 0.07% 254
2022
Q2
$677K Buy
34,553
+423
+1% +$9.92K 0.07% 249
2022
Q1
$1M Sell
34,130
-24,186
-41% -$722K 0.09% 215
2021
Q4
$2.27M Buy
58,316
+217
+0.4% +$8.66K 0.2% 117
2021
Q3
$2.35M Buy
58,099
+304
+0.5% +$12.3K 0.21% 111
2021
Q2
$2.41M Buy
+57,795
New +$2.19M 0.35% 75

Other funds holding BSTZ

Transcend Capital Advisors's BSTZ Position: Q4 2023 in Review

Transcend Capital Advisors sold out of BlackRock Science and Technology Term Trust (BSTZ) in Q4 2023, closing a stake of 15,559 shares — an estimated $257K sold.

Transcend Capital Advisors first reported a position in BSTZ in Q2 2021 and held it in 10 quarters. The position peaked at $2.41M in Q2 2021. 107 funds tracked by Wall St. Rank hold BSTZ as of Q4 2023.

  • Transcend Capital Advisors reported no remaining BlackRock Science and Technology Term Trust position as of Q4 2023 after selling out during the quarter.
  • Transcend Capital Advisors sold 15,559 BlackRock Science and Technology Term Trust shares in Q4 2023, an estimated $257K.
  • Transcend Capital Advisors first reported a position in BlackRock Science and Technology Term Trust in Q2 2021 and held it in 10 quarters.
  • Transcend Capital Advisors's BlackRock Science and Technology Term Trust position peaked at $2.41M in Q2 2021.
  • 107 funds tracked by Wall St. Rank held BlackRock Science and Technology Term Trust as of Q4 2023.

Based on Transcend Capital Advisors's 13F filing for Q4 2023, filed 5 Feb 2024.